Pancreatic Insufficiency
Information
- Disease name
- Pancreatic Insufficiency
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05700604 | Completed | Hypoglycemia and Glucagon Response in CF | January 1, 2020 | December 31, 2020 | |
| NCT00406536 | Completed | Phase 2 | Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI | January 2007 | June 2012 |
| NCT00432861 | Completed | Phase 3 | Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis | January 2007 | September 2007 |
| NCT00513682 | Completed | Phase 3 | Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI) | July 2007 | April 2008 |
| NCT00535756 | Completed | Phase 4 | Creon After Pancreatic Surgery | April 2008 | June 2011 |
| NCT00572975 | Completed | Phase 4 | Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea | August 2006 | March 2008 |
| NCT00705978 | Completed | Phase 3 | Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis | June 2008 | May 2010 |
| NCT00763412 | Completed | N/A | Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis | November 2006 | January 2013 |
| NCT00880100 | Completed | Phase 3 | Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF) | April 2009 | November 2009 |
| NCT01144507 | Completed | Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis | January 12, 2010 | June 14, 2023 | |
| NCT01710644 | Completed | Phase 1/Phase 2 | Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis | May 2013 | August 2014 |
| NCT01879228 | Completed | N/A | Effect of Chronic Incretin-based Therapy in Cystic Fibrosis | June 2013 | March 2020 |
| NCT01988350 | Completed | Pancreatic Insufficiency Secondary to Tobacco Exposure | May 2013 | August 2013 | |
| NCT02979340 | Completed | MRI to Characterize and Predict CF Liver Disease in PUSH Cohort | January 27, 2017 | December 27, 2019 | |
| NCT03551691 | Completed | Phase 2 | Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI) | August 7, 2018 | November 2, 2022 |
| NCT00095732 | Completed | Phase 2 | Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency | June 2004 | March 2005 |
| NCT01851694 | Recruiting | N/A | Beta-cell Response to Incretin Hormones in Cystic Fibrosis | May 2013 | December 2025 |
| NCT05466838 | Recruiting | N/A | PERT to Improve Quality of Life in Patients Undergoing Pancreaticoduodenectomy: A Pilot Randomized Controlled Trial | January 6, 2023 | August 31, 2024 |
| NCT04731272 | Recruiting | Phase 2 | GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance | April 20, 2021 | June 30, 2027 |
| NCT02985801 | Terminated | Phase 1/Phase 2 | PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer | December 2016 | April 2019 |
| NCT01012908 | Unknown status | Phase 2/Phase 3 | Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency | March 2010 | June 2011 |
| NCT03450772 | Unknown status | Phase 3 | Equivalence Study to Compare Two Strengths of Creon in China | August 31, 2017 | April 30, 2022 |
| NCT03279653 | Unknown status | Pancreatic Exocrine Insufficiency After Bariatric Surgery | September 1, 2017 | December 1, 2018 |